Literature DB >> 22863739

Mesenchymal stem cells in tumor development: emerging roles and concepts.

Benjamin G Cuiffo1, Antoine E Karnoub.   

Abstract

Mesenchymal stem cells (MSCs) are multipotent progenitor cells that participate in the structural and functional maintenance of connective tissues under normal homeostasis. They also act as trophic mediators during tissue repair, generating bioactive molecules that help in tissue regeneration following injury. MSCs serve comparable roles in cases of malignancy and are becoming increasingly appreciated as critical components of the tumor microenvironment. MSCs home to developing tumors with great affinity, where they exacerbate cancer cell proliferation, motility, invasion and metastasis, foster angiogenesis, promote tumor desmoplasia and suppress anti-tumor immune responses. These multifaceted roles emerge as a product of reciprocal interactions occurring between MSCs and cancer cells and serve to alter the tumor milieu, setting into motion a dynamic co-evolution of both tumor and stromal tissues that favors tumor progression. Here, we summarize our current knowledge about the involvement of MSCs in cancer pathogenesis and review accumulating evidence that have placed them at the center of the pro-malignant tumor stroma.

Entities:  

Mesh:

Year:  2012        PMID: 22863739      PMCID: PMC3427236          DOI: 10.4161/cam.20875

Source DB:  PubMed          Journal:  Cell Adh Migr        ISSN: 1933-6918            Impact factor:   3.405


  178 in total

1.  Culture and characterization of human bone marrow mesenchymal stem cells.

Authors:  Bruno Delorme; Pierre Charbord
Journal:  Methods Mol Med       Date:  2007

2.  Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation.

Authors:  Konstantinos E Hatzistergos; Henry Quevedo; Behzad N Oskouei; Qinghua Hu; Gary S Feigenbaum; Irene S Margitich; Ramesh Mazhari; Andrew J Boyle; Juan P Zambrano; Jose E Rodriguez; Raul Dulce; Pradip M Pattany; David Valdes; Concepcion Revilla; Alan W Heldman; Ian McNiece; Joshua M Hare
Journal:  Circ Res       Date:  2010-07-29       Impact factor: 17.367

3.  Bloodstream cells phenotypically identical to human mesenchymal bone marrow stem cells circulate in large amounts under the influence of acute large skin damage: new evidence for their use in regenerative medicine.

Authors:  E Mansilla; G H Marín; H Drago; F Sturla; E Salas; C Gardiner; S Bossi; R Lamonega; A Guzmán; A Nuñez; M A Gil; G Piccinelli; R Ibar; C Soratti
Journal:  Transplant Proc       Date:  2006-04       Impact factor: 1.066

4.  Gap junction-mediated import of microRNA from bone marrow stromal cells can elicit cell cycle quiescence in breast cancer cells.

Authors:  Philip K Lim; Sarah A Bliss; Shyam A Patel; Marcelo Taborga; Meneka A Dave; Larissa A Gregory; Steven J Greco; Margarette Bryan; Prem S Patel; Pranela Rameshwar
Journal:  Cancer Res       Date:  2011-02-22       Impact factor: 12.701

5.  Mesenchymal stem cells promote tumor engraftment and metastatic colonization in rat osteosarcoma model.

Authors:  Shinji Tsukamoto; Kanya Honoki; Hiromasa Fujii; Yasuaki Tohma; Akira Kido; Toshio Mori; Toshifumi Tsujiuchi; Yasuhito Tanaka
Journal:  Int J Oncol       Date:  2011-10-03       Impact factor: 5.650

Review 6.  Mesenchymal stem cells for treatment of acute and chronic graft-versus-host disease, tissue toxicity and hemorrhages.

Authors:  O Ringden; K Le Blanc
Journal:  Best Pract Res Clin Haematol       Date:  2011-02-25       Impact factor: 3.020

Review 7.  Regulatory-T-cell inhibition versus depletion: the right choice in cancer immunotherapy.

Authors:  Mario P Colombo; Silvia Piconese
Journal:  Nat Rev Cancer       Date:  2007-11       Impact factor: 60.716

8.  Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells.

Authors:  R M Dwyer; S M Potter-Beirne; K A Harrington; A J Lowery; E Hennessy; J M Murphy; F P Barry; T O'Brien; M J Kerin
Journal:  Clin Cancer Res       Date:  2007-09-01       Impact factor: 12.531

9.  Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism.

Authors:  Farida Djouad; Louis-Marie Charbonnier; Carine Bouffi; Pascale Louis-Plence; Claire Bony; Florence Apparailly; Céline Cantos; Christian Jorgensen; Danièle Noël
Journal:  Stem Cells       Date:  2007-05-17       Impact factor: 6.277

10.  Mesenchymal precursor cells in the blood of normal individuals.

Authors:  N J Zvaifler; L Marinova-Mutafchieva; G Adams; C J Edwards; J Moss; J A Burger; R N Maini
Journal:  Arthritis Res       Date:  2000-08-31
View more
  66 in total

Review 1.  Microenvironmental regulation of tumor progression and metastasis.

Authors:  Daniela F Quail; Johanna A Joyce
Journal:  Nat Med       Date:  2013-11       Impact factor: 53.440

Review 2.  Engineered Mesenchymal Stem Cells for Targeting Solid Tumors: Therapeutic Potential beyond Regenerative Therapy.

Authors:  Shen Cheng; Susheel Kumar Nethi; Sneha Rathi; Buddhadev Layek; Swayam Prabha
Journal:  J Pharmacol Exp Ther       Date:  2019-06-07       Impact factor: 4.030

Review 3.  Placental mesenchymal stromal cells as an alternative tool for therapeutic angiogenesis.

Authors:  Suja Ann Mathew; Charuta Naik; Paul A Cahill; Ramesh R Bhonde
Journal:  Cell Mol Life Sci       Date:  2019-08-29       Impact factor: 9.261

Review 4.  Multipotent mesenchymal stromal cells: A promising strategy to manage alcoholic liver disease.

Authors:  Fernando Ezquer; Flavia Bruna; Sebastián Calligaris; Paulette Conget; Marcelo Ezquer
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

5.  Stem cell bioprocess engineering towards cGMP production and clinical applications.

Authors:  Sébastien Sart; Yves-Jacques Schneider; Yan Li; Spiros N Agathos
Journal:  Cytotechnology       Date:  2014-02-06       Impact factor: 2.058

Review 6.  The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells?

Authors:  Vicki Plaks; Niwen Kong; Zena Werb
Journal:  Cell Stem Cell       Date:  2015-03-05       Impact factor: 24.633

Review 7.  Biointerfacing and Applications of Cell Membrane-Coated Nanoparticles.

Authors:  Ashley V Kroll; Ronnie H Fang; Liangfang Zhang
Journal:  Bioconjug Chem       Date:  2016-11-16       Impact factor: 4.774

8.  Cancer cells enter dormancy after cannibalizing mesenchymal stem/stromal cells (MSCs).

Authors:  Thomas J Bartosh; Mujib Ullah; Suzanne Zeitouni; Joshua Beaver; Darwin J Prockop
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-03       Impact factor: 11.205

9.  Extracellular acidity strengthens mesenchymal stem cells to promote melanoma progression.

Authors:  Silvia Peppicelli; Francesca Bianchini; Alessandra Toti; Anna Laurenzana; Gabriella Fibbi; Lido Calorini
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 10.  The cancer stem cell niche: cross talk between cancer stem cells and their microenvironment.

Authors:  Jun Ye; Dang Wu; Pin Wu; Zhigang Chen; Jian Huang
Journal:  Tumour Biol       Date:  2014-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.